Trial intelligence / Profile preview

[68Ga]Ga-FFD PET Imaging in Healthy Volunteers and Adult Patients With Solid Tumors

NCT07708103Phase 1Not yet recruiting

Start
Jul 2026
Primary completion
Jul 2027
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of FFD in solid tumor. Primary endpoint: Visual and standardized uptake values assessment of lesions and biodistribution at 1 month. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

FFD
03

Conditions

solid tumor

Beyond the preview

Go deeper on NCT07708103.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07708103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call